CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Auditor change · Bylaws or fiscal year change · Shareholder vote results
- NT 10-Q Other NT 10-Q
- 4 Insider Changes in Ownership
- DEFR14A Other DEFR14A
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K/A Event Material agreement · Unregistered share sale
Page 15 of 36 · 707 filings